SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance

Abstract Background Methyltransferase SETDB1 is highly expressed in breast cancer (BC), however, the mechanisms by which SETDB1 promotes BC progression to endocrine therapy resistance remains elusive. In this study, we examined the mechanisms by which SETDB1 contribute to BC endocrine therapy resist...

Descripción completa

Detalles Bibliográficos

Autores principales:	Zexuan Liu, Junhao Liu, Behnam Ebrahimi, Uday P. Pratap, Yi He, Kristin A. Altwegg, Weiwei Tang, Xiaonan Li, Zhao Lai, Yidong Chen, Liangfang Shen, Gangadhara R. Sareddy, Suryavathi Viswanadhapalli, Rajeshwar R. Tekmal, Manjeet K. Rao, Ratna K. Vadlamudi
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2022-04-01
Colección:	Breast Cancer Research
Materias:	SETDB1 Akt PELP1 Breast cancer Therapy resistance
Acceso en línea:	https://doi.org/10.1186/s13058-022-01520-4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!